BioMarin Pharmaceuticals BMRN Return on invested capital

Return on invested capital at other companies

Zevra Therapeutics, Inc.ZVRA

71.7%+48.7pp

Agios PharmaceuticalsAGIO

-40%-5.0pp

RegenxbioRGNX

-103.9%+612pp

Tyra Biosciences, Inc.TYRA

-53.2%-6.2pp

Crinetics PharmaceuticalsCRNX

-45.1%+1.9pp

MBX Biosciences, Inc.MBX

-33%—

FAQ

What is BioMarin Pharmaceuticals's return on invested capital?

BioMarin Pharmaceuticals (BMRN) reported return on invested capital of 1.5% in Q2 2026.

How has BioMarin Pharmaceuticals's return on invested capital changed year-over-year?

BioMarin Pharmaceuticals's return on invested capital decreased by 86.2% year-over-year, from 10.7% to 1.5%.

What is the long-term trend for BioMarin Pharmaceuticals's return on invested capital?

Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's return on invested capital has grown at a 38.2% compound annual growth rate (CAGR), from -1.3% to 6.6%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.